KORU Medical Systems Inc. Reports on Recent Performance and Market Position

KORU Medical Systems, Inc., a health care equipment and supply company based in Mahwah, United States, has recently been in the spotlight due to its performance on the Nasdaq. The company, which specializes in designing and manufacturing medical devices and supplies, particularly subcutaneous infusion devices for immunoglobulin therapies, has seen its share price fluctuate over the past year.

As of August 4, 2025, KORU Medical Systems closed at $3.28 per share. This figure is notably below the 52-week high of $5.05, recorded on February 3, 2025, and above the 52-week low of $1.86, observed on April 8, 2025. The company’s market capitalization stands at approximately $159.65 million.

The company’s focus remains on providing solutions for patients with chronic illnesses, such as primary immunodeficiencies (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). Despite its specialized market, KORU Medical Systems has faced challenges, reflected in its price-to-earnings ratio of -28.238, indicating a period of financial adjustment or losses.

KORU Medical Systems continues to innovate within the health care equipment and supplies sector, aiming to improve patient outcomes through advanced medical device technology. The company’s commitment to addressing the needs of patients with chronic conditions remains a cornerstone of its business strategy.

As the health care industry evolves, KORU Medical Systems is poised to leverage its expertise in subcutaneous infusion devices to meet the growing demand for effective immunoglobulin therapies. Investors and stakeholders will be closely monitoring the company’s progress in navigating market challenges and capitalizing on opportunities within the health care sector.